Armata Pharmaceuticals (ARMP) Other Operating Expenses (2014 - 2026)

Armata Pharmaceuticals has disclosed Other Operating Expenses across 8 years of filings, most recently posting -$2.0 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$2.0 million, down 8.05% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.2 million (up 71.38% YoY), and the FY2025 annual result was -$2.1 million, up 74.54% from the prior year.
• Other Operating Expenses came in at -$2.0 million for Q1 2026 at Armata Pharmaceuticals, down from $3.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $3.2 million in Q4 2025 to a low of -$2.2 million in Q1 2024.
• The 3-year median for Other Operating Expenses is -$2.0 million (2025), against an average of -$1.4 million.
• Across the five-year window, Other Operating Expenses soared 245.43% in 2025 and dropped 8.05% in 2026, its largest moves.
• Armata Pharmaceuticals' Other Operating Expenses stood at -$2.2 million in 2024, then jumped by 245.43% to $3.2 million in 2025, then plunged by 163.52% to -$2.0 million in 2026.
• The last three Other Operating Expenses figures came in at -$2.0 million (Q1 2026), $3.2 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.